申请人:Bittman Robert
公开号:US09359389B2
公开(公告)日:2016-06-07
The invention relates to novel caged ceramide 1-phosphate (C1P), caged ceramide 1-phosphate derivatives(C1P), and the method of using them for delivering C1P intracellularly in vitro and in vivo, for research and therapeutic purposes. Therapeutic purposes include treatment of diseases associated with cell death, such as neurodegerative diseases, including Alzheimer's disease. The disclosed compositions may also be used for wound healing.
本发明涉及一种新型的笼状鞘氨醇1-磷酸酯(C1P),笼状鞘氨醇1-磷酸酯衍生物(C1P)及其使用方法,用于体外和体内递送C1P,以进行研究和治疗目的。治疗目的包括治疗与细胞死亡有关的疾病,如神经退行性疾病,包括阿尔茨海默病。所披露的组合物还可用于伤口愈合。